Top in endocrinology: New name for diabetes insipidus; gestational diabetes and CVD risk
National and international endocrine, nephrology and pediatric societies are proposing a name change for diabetes insipidus.
“Confusion with diabetes mellitus has led to bad experiences and outcomes of patients with diabetes insipidus when they are under the care of non-endocrine specialists,” Mirjam Christ-Crain, MD, PhD, a professor of endocrinology at University Hospital Basel in Switzerland, told Healio. “In several patients with central diabetes insipidus, desmopressin treatment was withheld with serious adverse outcomes, even leading to death.”
The societies are proposing to change the name of diabetes insipidus to arginine vasopressin deficiency and arginine vasopressin resistance. It was the top story in endocrinology last week.
Another top story was about an increased risk for CVD and cerebrovascular disease among women with gestational diabetes.
Read these and more top stories in endocrinology below:
Consensus group proposes new name for diabetes insipidus
A group of representatives from national and international endocrine, nephrology and pediatric societies has proposed changing the name of diabetes insipidus to arginine vasopressin deficiency and arginine vasopressin resistance. Read more.
Gestational diabetes increases risks for CV, cerebrovascular diseases
Women with gestational diabetes have increased risks for overall and specific types of cardiovascular and cerebrovascular diseases, whether or not they go on to develop type 2 diabetes, according to study data published in The BMJ. Read more.
ADA issues practical advice for use of automated insulin delivery systems
Open communication between stakeholders and patient education are two underlying themes in a new series of recommendations provided in a consensus report on the use of automated insulin delivery systems. Read more.
Type 2 diabetes risk lower for women with diabetes history, optimal risk factor levels
Women with a history of gestational diabetes can lower their risk for developing type 2 diabetes by optimizing modifiable risk factors for the disease, such as weight, diet, physical activity and tobacco and alcohol use. Read more.
Girls with type 1 diabetes lose trabecular bone volume
Adolescent girls with type 1 diabetes lost trabecular volumetric bone mineral density over 1 year compared with gains for girls without diabetes, with greater loss at higher HbA1c levels, according to a speaker. Read more.